First-quarter revenue increased 13.3% year over year to $1.1 billion, according to financial documents published Feb. 26. Demand for services was high, particularly in the outpatient setting, compared to the prior year.
First-quarter expenses rose 8.4% year over year to $1.1 billion. Key contributors to the rise in costs were internal labor expenses, physician fees and supply costs.
After accounting for nonoperating items, such as investment returns, OSF reported a net profit of $179.8 million in the fiscal first quarter of 2023, up from an $81.8 million gain in the prior-year period.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
